Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gurdip Mann in lab, working on chagas vaccine developmentChagas disease (caused by Trypanosoma cruzi) remains a leading neglected tropical disease in the Americas. Approximately 7.5 million people are living with Chagas disease, mostly in poor regions of Central and South America, although thousands of T. cruzi-infected individuals also live in the United States and different European countries. This infection is associated with 546,000 disability adjusted life years and 10,300 annual deaths. There is no a licensed vaccine yet on the market and our group is currently working towards the development of a chagas vaccine